Xiaoli Wei
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Weiwei Gao (1 shared paper)Jie Gao (1 shared paper)Liangfang Zhang (1 shared paper)Ronnie H. Fang (1 shared paper)Diana Dehaini (1 shared paper)Yao Jiang (1 shared paper)Jiarong Zhou (1 shared paper)Brian T. Luk (1 shared paper)
- Journals
- International Journal of Molecular Sciences (4 papers)Acta Pharmacologica Sinica (2 papers)BioMed Research International (2 papers)Cancer Medicine (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoli Wei
29 papers receiving 782 citations
Xiaoli Wei's Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 211
- Biomaterials 133
- Oncology 186
- Biomedical Engineering 310
- Molecular Biology 309
Countries citing papers authored by Xiaoli Wei
This map shows the geographic impact of Xiaoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Wei more than expected).
Fields of papers citing papers by Xiaoli Wei
This network shows the impact of papers produced by Xiaoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Wei. The network helps show where Xiaoli Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity Hit paper breakdown → | 2017 | 442 |
| 2 | 2017 | 44 | |
| 3 | 2017 | 41 | |
| 4 | 2014 | 35 | |
| 5 | 2020 | 28 | |
| 6 | 2021 | 18 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2017 | 15 | |
| 12 | 2018 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 12 | |
| 15 | 2023 | 8 | |
| 16 | 2022 | 8 | |
| 17 | [Change of cytokines in mice with Echinococcus multilocularis infection]. | 2004 | 7 |
| 18 | 1998 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2017 | 6 |
About Xiaoli Wei
Xiaoli Wei is a scholar working on Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 31 papers that have together received 793 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (2 papers), Protein Degradation and Inhibitors (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Immunology (211 citations), Biomaterials (133 citations), Oncology (186 citations), Biomedical Engineering (310 citations) and Molecular Biology (309 citations). Xiaoli Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weiwei Gao, Jie Gao, Liangfang Zhang, Ronnie H. Fang, Diana Dehaini, Yao Jiang, Jiarong Zhou, Brian T. Luk, Ashley V. Kroll and Hui Sheng. Their work appears in journals such as International Journal of Molecular Sciences, Acta Pharmacologica Sinica, BioMed Research International, Cancer Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.